Sector ratings Laboratorios Farmaceuticos Rovi, S.A.

Stocks

Real-time Estimate Tradegate 10:28:43 2026-08-14 am EDT			5-day change	1st Jan Change
57.45 ^EUR	-1.20%		-1.63%	-9.61%

Jul. 23	Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026
Jul. 23	Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
LABORATORIOS FARMACEUTICOS ROVI, S.A.	3.43B		BBB
ELI LILLY AND COMPANY	1,078B		A
JOHNSON & JOHNSON	632B	-	BBB	-	-
ABBVIE INC.	443B	-	AA	-	-
ROCHE HOLDING AG	356B		AA
NOVARTIS AG	289B		AAA
ASTRAZENECA PLC	245B		A
AMGEN INC.	226B		A
NOVO NORDISK A/S	204B		A
GILEAD SCIENCES, INC.	171B		AA
PFIZER INC.	153B		A
VERTEX PHARMACEUTICALS INCORPORATED	131B		AA
BRISTOL-MYERS SQUIBB COMPANY	132B		A
SANOFI	106B		AA
GSK PLC	100B		AA
CHUGAI PHARMACEUTICAL CO., LTD.	74.07B		AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	55.7B		AA
BAYER AG	54.47B		AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	52.51B		AA
HALEON PLC	42.55B		AA
Average	227.41B		AA
Weighted average by Cap.			AA